CN112137111A - Formula and preparation method of product for improving sleep and skin brightness - Google Patents
Formula and preparation method of product for improving sleep and skin brightness Download PDFInfo
- Publication number
- CN112137111A CN112137111A CN202010990632.2A CN202010990632A CN112137111A CN 112137111 A CN112137111 A CN 112137111A CN 202010990632 A CN202010990632 A CN 202010990632A CN 112137111 A CN112137111 A CN 112137111A
- Authority
- CN
- China
- Prior art keywords
- product
- skin brightness
- percent
- improving
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000009472 formulation Methods 0.000 title description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 18
- 229920001202 Inulin Polymers 0.000 claims abstract description 15
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 15
- 229940029339 inulin Drugs 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 10
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 9
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 9
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 9
- 229940013618 stevioside Drugs 0.000 claims abstract description 9
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019202 steviosides Nutrition 0.000 claims abstract description 9
- 229940026510 theanine Drugs 0.000 claims abstract description 9
- 239000000047 product Substances 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 14
- 238000009924 canning Methods 0.000 claims description 7
- 238000007580 dry-mixing Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 4
- 230000003860 sleep quality Effects 0.000 abstract description 6
- 230000007413 intestinal health Effects 0.000 abstract description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 14
- 206010022437 insomnia Diseases 0.000 description 14
- 230000000694 effects Effects 0.000 description 10
- 230000001976 improved effect Effects 0.000 description 9
- 206010061428 decreased appetite Diseases 0.000 description 8
- 208000004232 Enteritis Diseases 0.000 description 6
- 206010000084 Abdominal pain lower Diseases 0.000 description 5
- 206010015137 Eructation Diseases 0.000 description 5
- 206010067171 Regurgitation Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 208000027687 belching Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 238000005282 brightening Methods 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000003326 hypnotic agent Substances 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a formula of a product for improving sleep and skin brightness and a preparation method thereof, wherein the product is prepared from the following raw materials in parts by weight: 51-62% of lactalbumin powder, 34-42% of inulin, 1.8-2.2% of haematococcus pluvialis, 1.8-2.2% of theanine and 0.9-1.1% of stevioside. The product of the invention improves sleep, improves sleep quality and quickly falls asleep; maintaining vigor, concentrating energy, improving intestinal health, and improving skin brightness.
Description
Technical Field
The invention relates to the field of health products, in particular to a formula of a product for improving sleep and skin brightness and a preparation method thereof.
Background
About one third of a person's life is spent asleep. The high quality of sleep can enable the brain and body of people to be fully rested, adjusted and recovered, which is important for daily life and work. On the contrary, if people do not have sufficient sleep and rest, daily life and work are seriously affected, and the health of people is also affected.
With the acceleration of modern life rhythm and the increase of social pressure, the sleep quality problem is increasingly highlighted. An international survey in 2005 showed that the rate of insomnia in france and italy was 37.2%, 6.6% in japan and 27.1% in the united states. Foreign epidemiological studies have shown that 15% to 35% of adults have a low sleep quality problem.
Poor sleep quality can affect work and life, insomnia can cause bad integral complexion of people, the complexion is waxy yellow, and the integral state is not good when seen by other people; most people with sleep disorder have the problem of insomnia by orally taking hypnotics, but the long-term oral administration of hypnotics is easy to cause dependence on human bodies, thereby further influencing the body health. Therefore, there is a need for a health product that can improve sleep, enhance skin brightness, and improve the overall condition of the human body.
Disclosure of Invention
The invention aims to provide a formula of a product for improving sleep and improving skin brightness and a preparation method thereof, which can improve and promote sleep, improve sleep quality, enable people to fall asleep quickly and enhance skin brightness.
In order to solve the technical problems, the invention adopts the following technical scheme:
the invention provides a product for improving sleep and skin brightness, which is prepared from the following raw materials in parts by weight: 51-62% of lactalbumin powder, 34-42% of inulin, 1.8-2.2% of haematococcus pluvialis, 1.8-2.2% of theanine and 0.9-1.1% of stevioside.
The invention also provides a preparation method of the product for improving sleep and skin brightness, which comprises the following specific steps:
1) weighing the raw materials according to the weight ratio;
2) mixing in dry mixing tank, maintaining temperature at 20-25 deg.C and humidity below 50%, turning for 2-20 min, mixing to obtain final product, and canning.
The taking method comprises the following steps: the product of the invention is orally taken, can be taken by flushing water, and is 8g per day.
The invention has the beneficial effects that: improving sleep, improving sleep quality, and rapidly falling asleep; maintaining vigor, concentrating energy, improving intestinal health, and improving skin brightness.
The beneficial effects of the invention are further explained by combining the main components in the invention as follows:
the efficacy of inulin is as follows: 1. controlling blood fat: can effectively reduce serum Total Cholesterol (TC) and low density lipoprotein cholesterol (LDL-C); 9g of inulin is added into the daily grain breakfast for 4 weeks, so that the total cholesterol is reduced by 8.2 percent, and the triglyceride is greatly reduced by 26.5 percent;
2. and (3) reducing blood sugar: the reduction in fasting plasma glucose is a result of short chain fatty acids produced by fermentation of fructooligosaccharides in the colon;
3. and (3) promoting the absorption of minerals: the inulin can greatly improve the absorption of minerals such as Ca2+, Mg2+, Zn2+, Cu2+, Fe2 +;
4. regulating intestinal microbial flora, improving intestinal health, and preventing constipation;
inulin is a natural water-soluble dietary fiber, can hardly be hydrolyzed and digested by gastric acid, and is only utilized by beneficial microorganisms in colon, so that the intestinal environment is improved, gastrointestinal peristalsis can be enhanced after the inulin is ingested, the gastrointestinal function is improved, digestion and appetite are increased, and the immunity of the organism is improved.
5. Inhibiting the generation of toxic fermentation products, protecting liver, and preventing colon cancer;
6. the dietary fiber for preventing constipation and treating obesity reduces the retention time of food in the stomach and intestine, increases the excrement amount and effectively treats constipation;
7. has good antidepressant effect.
The health-care function of the inulin is as follows: 1. inulin can lower blood sugar level and reduce blood sugar concentration; 2. the functions of digestion and defecation are enhanced, and the traditional Chinese medicine has a special effect on treating constipation; 3. the metabolism function is enhanced, and scalding and other wound wounds are quickly recovered; 4. beautifying the skin; 5. eliminating eczema; 6. has special effect on colorectal cancer; 7. improving vascular disorders; 8. the weight-losing efficacy; 9. protecting liver function; 10. low energy; 11. rapidly increasing the number of bifidobacteria in the intestinal tract; 12. improving skin itch associated with diabetic patients; 13. can improve mild and moderate depression and anxiety.
Efficacy of haematococcus pluvialis: has effects of improving sleep and enhancing immunity.
The function of the lactalbumin powder is as follows: 1. regulating protein balance; 2. beneficial to the development of the immune system; 3. is beneficial to the growth of internal organs; 4. is a micronutrient, is a matrix of intestinal microorganisms, and plays an important role in the development of intestinal cell walls and nervous systems.
The milk white protein powder has the health-care effect: contains high tryptophan content, and is effective in relieving stress, improving work performance, improving sleep, and improving abstract visual memory.
The efficacy of theanine is as follows: 1. modulating changes in neurotransmitters in the brain; 2. the learning ability and the memory are improved; 3. a sedative effect; 4. improving menstrual period syndrome; 5. protecting nerve cells; 6. the function of lowering blood pressure; 7. enhance the curative effect of the anticancer drug.
Stevioside is a natural low calorie sweetener.
Detailed Description
The technical solutions of the present invention will be described clearly and completely in the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A product for improving sleep and skin brightness is prepared from the following raw materials by weight: 150g of lactalbumin powder, 100g of inulin, 5g of haematococcus pluvialis, 6g of theanine and 3g of stevioside.
The preparation method of the product for improving sleep and skin brightness comprises the following specific steps:
1) weighing the raw materials according to the weight;
2) mixing in dry mixing tank, maintaining temperature at 22 deg.C and humidity at 40%, turning over for 5 min, mixing to obtain final product, and canning.
Example 2
A product for improving sleep and skin brightness is prepared from the following raw materials by weight: 160g of lactalbumin powder, 102g of inulin, 5.1g of haematococcus pluvialis, 5.9g of theanine and 2.9g of stevioside.
The preparation method of the product for improving sleep and skin brightness comprises the following specific steps:
1) weighing the raw materials according to the weight;
2) mixing in dry mixing tank, maintaining temperature at 25 deg.C and humidity at 30%, turning over for 10 min, mixing to obtain final product, and canning.
Example 3
A product for improving sleep and skin brightness is prepared from the following raw materials by weight: 140g of lactalbumin powder, 105g of inulin, 5.2g of haematococcus pluvialis, 5.5g of theanine and 2.7g of stevioside.
The preparation method of the product for improving sleep and skin brightness comprises the following specific steps:
1) weighing the raw materials according to the weight;
2) mixing in dry mixing tank, maintaining temperature at 20 deg.C and humidity at 49%, turning over for 20 min, mixing to obtain final product, and canning.
Example 4
A product for improving sleep and skin brightness is prepared from the following raw materials by weight: 145g of lactalbumin powder, 108g of inulin, 4.8g of haematococcus pluvialis, 5.8g of theanine and 2.9g of stevioside.
The preparation method of the product for improving sleep and skin brightness comprises the following specific steps:
1) weighing the raw materials according to the weight;
2) mixing in dry mixing tank, maintaining temperature at 25 deg.C and humidity at 20%, turning over for 18 min, mixing to obtain final product, and canning.
Example 5
A product for improving sleep and skin brightness is prepared from the following raw materials by weight: 148g of lactalbumin powder, 95g of inulin, 5g of haematococcus pluvialis, 5.4g of theanine and 2.8g of stevioside.
The preparation method of the product for improving sleep and skin brightness comprises the following specific steps:
1) weighing the raw materials according to the weight;
2) mixing in dry mixing tank, maintaining temperature at 23 deg.C and humidity at 45%, turning over for 13 min, mixing to obtain final product, and canning.
Clinical trials applying the present invention:
the experimental apparatus comprises 150 testers, wherein 75 male testers and 75 female testers are 75, the age is 15-60 years old, 50 insomnia testers and 50 inappetence testers, and 50 testers of enteritis patients, and 150 testers are divided into 5 groups, and the 5 groups are similar as much as possible, so that the testers have comparability.
The treatment method comprises the following steps: the preparation is administered orally once a day, 8g each time, and observed after two months.
Diagnostic criteria
And (3) curing: the discomfort phenomena of insomnia, inappetence, abdominal pain, abdominal distension, vomiting and the like disappear, and the people can eat and sleep normally; the method has the following advantages: the discomfort phenomena of insomnia, inappetence, abdominal pain, abdominal distension, vomiting and the like are relieved.
As a result: in example 1, 40 insomnia test persons were cured by 50 insomnia test persons; the 10 bits are valid; the cure rate is 80 percent, and the effective rate is 100 percent.
45 patients were cured by 50 patients with inappetence; 5 bits are valid; the cure rate is 90 percent, and the effective rate is 100 percent.
The 50 enteritis patients cured 35 patients, and the phenomena of acid regurgitation, belching and lower abdominal pain do not occur after eating; 8 bits are valid; the cure rate is 70 percent, and the effective rate is 86 percent.
The skin brightness of 150 testers is improved, and the skin brightening effect is 100%.
In example 2, 46 insomnia testers were cured by 50 insomnia testers; 4 bits are valid; the cure rate is 92 percent, and the effective rate is 100 percent.
42 patients were cured by 50 anorexic test persons; 8 bits are valid; the cure rate is 84 percent, and the effective rate is 100 percent.
The 50 enteritis patients cured 45 patients, and the phenomena of acid regurgitation, belching and lower abdominal pain do not occur after eating; 5 bits are valid; the cure rate is 90 percent, and the effective rate is 100 percent.
The skin brightness of 150 testers is improved, and the skin brightening effect is 100%.
In example 3, 48 insomnia test persons were cured by 50 insomnia test persons; 2 bits are valid; the cure rate is 96 percent, and the effective rate is 100 percent.
45 patients were cured by 50 patients with inappetence; 5 bits are valid; the cure rate is 90 percent, and the effective rate is 100 percent.
The 50 enteritis patients cured 40 patients, and the phenomena of acid regurgitation, belching and lower abdominal pain do not occur after eating; 8 bits are valid; the cure rate is 80 percent, and the effective rate is 96 percent.
The skin brightness of 150 testers is improved, and the skin brightening effect is 100%.
49 insomnia test persons were cured in 50 persons in example 4; 1 bit is valid; the cure rate is 98 percent, and the effective rate is 100 percent.
47 patients were cured by 50 patients with inappetence; 3 bits are valid; the cure rate is 94 percent, and the effective rate is 100 percent.
The 50 enteritis patients cured 42 patients, and the phenomena of acid regurgitation, belching and lower abdominal pain do not occur after eating; 8 bits are valid; the cure rate is 84 percent, and the effective rate is 100 percent.
The skin brightness of 150 testers is improved, and the skin brightening effect is 100%.
43 patients in example 5 were cured by 50 insomnia test persons; 7 bits are valid; the cure rate is 86 percent, and the effective rate is 100 percent.
45 patients were cured by 50 patients with inappetence; 5 bits are valid; the cure rate is 90 percent, and the effective rate is 100 percent.
The 50 enteritis patients cured 46 patients, and the phenomena of acid regurgitation, belching and lower abdominal pain do not occur after eating; 4 bits are valid; the cure rate is 92 percent, and the effective rate is 100 percent.
The skin brightness of 150 testers is improved, and the skin brightening effect is 100%.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.
Claims (2)
1. The product for improving sleep and skin brightness is characterized by being prepared from the following raw materials in parts by weight: 51-62% of lactalbumin powder, 34-42% of inulin, 1.8-2.2% of haematococcus pluvialis, 1.8-2.2% of theanine and 0.9-1.1% of stevioside.
2. A preparation method of a product for improving sleep and skin brightness comprises the following steps: the method comprises the following specific steps:
1) weighing the raw materials according to the weight ratio;
2) mixing in dry mixing tank, maintaining temperature at 20-25 deg.C and humidity below 50%, turning for 2-20 min, mixing to obtain final product, and canning.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010990632.2A CN112137111A (en) | 2020-09-19 | 2020-09-19 | Formula and preparation method of product for improving sleep and skin brightness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010990632.2A CN112137111A (en) | 2020-09-19 | 2020-09-19 | Formula and preparation method of product for improving sleep and skin brightness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112137111A true CN112137111A (en) | 2020-12-29 |
Family
ID=73893340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010990632.2A Pending CN112137111A (en) | 2020-09-19 | 2020-09-19 | Formula and preparation method of product for improving sleep and skin brightness |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112137111A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115474660A (en) * | 2021-05-31 | 2022-12-16 | 海南三圣堂生物科技有限公司 | Anti-aging sleep-aiding noni enzyme formula and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106473114A (en) * | 2015-08-24 | 2017-03-08 | 广州硕维食品技术有限公司 | A kind of anti-apolexis composition |
| CN108260790A (en) * | 2017-01-04 | 2018-07-10 | 永和食品（中国）股份有限公司 | A kind of nourishing albumen powder and preparation method thereof |
| CN108294213A (en) * | 2018-02-02 | 2018-07-20 | 云南瑞宝生物科技股份有限公司 | A kind of inulin solid beverage and preparation method thereof rich in astaxanthin |
| CN108338364A (en) * | 2017-11-22 | 2018-07-31 | 成都图径生物科技有限公司 | Composition for relieving asthenopia containing theanine and astaxanthin |
-
2020
- 2020-09-19 CN CN202010990632.2A patent/CN112137111A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106473114A (en) * | 2015-08-24 | 2017-03-08 | 广州硕维食品技术有限公司 | A kind of anti-apolexis composition |
| CN108260790A (en) * | 2017-01-04 | 2018-07-10 | 永和食品（中国）股份有限公司 | A kind of nourishing albumen powder and preparation method thereof |
| CN108338364A (en) * | 2017-11-22 | 2018-07-31 | 成都图径生物科技有限公司 | Composition for relieving asthenopia containing theanine and astaxanthin |
| CN108294213A (en) * | 2018-02-02 | 2018-07-20 | 云南瑞宝生物科技股份有限公司 | A kind of inulin solid beverage and preparation method thereof rich in astaxanthin |
Non-Patent Citations (2)
| Title |
|---|
| 郭本恒等主编: "《干酪科学与技术》", 31 May 2015, 中国轻工业出版社 * |
| 高俊全等主编: "《虾青素：健康新世纪的奥秘》", 31 July 2013, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115474660A (en) * | 2021-05-31 | 2022-12-16 | 海南三圣堂生物科技有限公司 | Anti-aging sleep-aiding noni enzyme formula and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104643250A (en) | Solid beverage capable of bidirectionally regulating body weight and improving subhealth | |
| CN105815514A (en) | Weight-losing quinoa milk tea | |
| CN103190483A (en) | Children growth promotion milk tea | |
| CN109820905A (en) | A kind of pharmaceutical composition and its application for treating insomnia | |
| CN114711374A (en) | Composite nutrient powder of ferment fibre and its preparation method | |
| CN112137111A (en) | Formula and preparation method of product for improving sleep and skin brightness | |
| CN105707378A (en) | Black-highland barley coffee with effect of slimming | |
| CN104222287A (en) | Anti-fatigue and anti-aging health-care milk and preparation method thereof | |
| CN103463407A (en) | Body regulating and blood sugar reducing capsule | |
| KR102000170B1 (en) | Food compositions for reducing body fat and improving intestinal function | |
| CN106474413B (en) | It is a kind of for treat the weakness of the spleen and the stomach children, eating accumulation, anorexia Orally administered composition | |
| CN115500508A (en) | Composition for preventing sugar and reducing fat and preparation method thereof | |
| CN114191515A (en) | Oral gel for dispelling dampness, invigorating stomach and improving immunity and preparation method thereof | |
| CN106035686A (en) | Super chenopodium quinoa willd health-preservation plant milk | |
| CN112690386A (en) | A dietetic composition with antioxidant and antibacterial effects and capable of enhancing cardiovascular and cerebrovascular and immunity | |
| CN110959797A (en) | Prebiotics soybean protein peptide solid beverage and preparation process thereof | |
| CN101700119B (en) | Oral administration preparation for improving subhealth symptom of adult | |
| KR20040097813A (en) | Composition containing Diet Neurotrophic Factor having anti-fatness functions | |
| CN1241487C (en) | Method for preparing health-care soymilk with food sleeping-care function contg. melatonin | |
| CN1233248C (en) | Method for preparing sour soymilk health-care food with sleeping-helping function contg. pineal hormone | |
| CN116076704B (en) | High-energy-density high-fiber-content homogenized food and preparation method thereof | |
| CN107412422A (en) | A kind of oral liquid that can improve body regulatory function | |
| EP3389666A1 (en) | Compositions comprising 3'-o-glucuronide epicatechin and methods of making and using such compositions | |
| CN115137060A (en) | Low-fermentation dietary composition for improving gastrointestinal dysfunction symptoms and preparation method thereof | |
| CN1241488C (en) | Method for preparing health-care milk food sleeping-care function contg. melatonin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201229 |